News | July 16, 2013

ImaCor Implements 24/7 hTEE Clinical Support Program

Clinical specialists available around-the-clock to provide hTEE customer service

hTEE 24/7 Clinical Support Program ImaCor

July 16, 2013 — ImaCor Inc. announced the implementation of the 24/7 hTEE Clinical Support Program.

ImaCor’s 24/7 hTEE Clinical Support Program ensures that a senior member of the company’s clinical specialist team is always available via phone, text and video-chat modalities to provide support to clinicians working at the patient bedside. 24/7 hTEE Clinical Support is an enhancement to the ImaCor Customer Service Program, and aligns with ImaCor’s educational commitment to their customers. The launch of this program coincides with the start of the critical care fellowship year.

“While introducing hTEE into our Neurointensive Care Unit, our team benefited from ImaCor's 24/7 hTEE Clinical Support Program,” commented Jacqueline S. Urtecho M.D., Neurointensive Care Physician at Thomas Jefferson University Hospital. “The ability to video-chat with an hTEE clinical specialist at any time complements the team’s ongoing training and ensures that we can apply hTEE confidently whenever our patients need it.”

“Around-the-clock guidance is often necessary during the implementation of new technologies,” said Donald Reiff M.D., director of the Trauma/Burn Unit at the University of Alabama Hospital at Birmingham. “ImaCor’s 24/7 hTEE Clinical Support Program is a best practice in the business, enabling any member of our team — including Fellows and Physician Assistants — to connect with an ImaCor hTEE specialist for day or night support.”

hTEE is the only technology in critical care that provides continuously available, direct visualization of heart filling and function in the ICU, enabling optimal post-operative hemodynamic management.

For more information: www.imacorinc.com

Related Content

ASE Releases Guidelines for Transesophageal Echo in Congenital Heart Disease
News | Ultrasound Transesophageal echo (TEE) | February 05, 2019
February 5, 2019 – The American Society of Echocardiography (ASE) released a new document that provides a comprehensi
Figure 1: Segmentation performed on the left atrium, left ventricle and mitral bioprosthesis. Landmarks are placed on the site of optimal transseptal access into the left atrium and the mitral PVL.

Figure 1: Segmentation performed on the left atrium, left ventricle and mitral bioprosthesis. Landmarks are placed on the site of optimal transseptal access into the left atrium and the mitral PVL.

Sponsored Content | Case Study | Ultrasound Transesophageal echo (TEE) | September 05, 2018 | Cyril Danielkutty B.E., Dillon Weiss, B.S., Chad A Kliger, M.D., M.S.
Transcatheter interventions have become a mainstay in cardiac care as treatments for structural and congenital heart
FDA Clears Visura Technologies' TEE Camera Assist Device System
Technology | Ultrasound Transesophageal echo (TEE) | July 10, 2018
July 10, 2018 — Evanston, Ill.-based startup Visura Technologies has received 510(k) clearance from the U.S.
Stroke2prevent Receives FDA 510(k) Clearance for A-View
Technology | Ultrasound Transesophageal echo (TEE) | June 20, 2017
June 20, 2017 — Dutch medical device company Stroke2prevent BV recently announced it has received U.S.
News | Ultrasound Transesophageal echo (TEE) | April 21, 2016
CS Medical announced the release of their newest product designed to aid in the circle of care for transesophageal echo...
Overlay Init